Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 19 studies | 30% ± 13% | |
classical monocyte | 14 studies | 24% ± 9% | |
monocyte | 7 studies | 21% ± 3% | |
endothelial cell | 6 studies | 21% ± 4% | |
dendritic cell | 6 studies | 27% ± 15% | |
mast cell | 5 studies | 20% ± 4% | |
conventional dendritic cell | 4 studies | 34% ± 9% | |
naive B cell | 4 studies | 18% ± 1% | |
fibroblast | 4 studies | 24% ± 5% | |
pericyte | 3 studies | 19% ± 3% |
Insufficient scRNA-seq data for expression of RARA at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 2366.77 | 1808 / 1809 | 100% | 45.07 | 470 / 472 |
thymus | 100% | 2895.33 | 651 / 653 | 99% | 32.36 | 600 / 605 |
breast | 100% | 3845.00 | 459 / 459 | 99% | 79.95 | 1104 / 1118 |
intestine | 100% | 2936.25 | 966 / 966 | 99% | 29.34 | 520 / 527 |
liver | 99% | 2522.47 | 224 / 226 | 100% | 31.69 | 404 / 406 |
ovary | 100% | 3796.81 | 180 / 180 | 99% | 33.42 | 424 / 430 |
prostate | 100% | 3214.52 | 245 / 245 | 98% | 19.17 | 492 / 502 |
lung | 100% | 5786.33 | 577 / 578 | 98% | 30.30 | 1127 / 1155 |
bladder | 100% | 3066.43 | 21 / 21 | 97% | 23.44 | 490 / 504 |
kidney | 100% | 2208.73 | 89 / 89 | 96% | 38.33 | 868 / 901 |
stomach | 99% | 1881.28 | 354 / 359 | 98% | 30.97 | 279 / 286 |
uterus | 100% | 3669.85 | 170 / 170 | 96% | 27.35 | 441 / 459 |
esophagus | 96% | 2253.76 | 1386 / 1445 | 99% | 31.34 | 181 / 183 |
adrenal gland | 100% | 2128.26 | 258 / 258 | 92% | 38.46 | 211 / 230 |
brain | 64% | 809.42 | 1703 / 2642 | 99% | 28.80 | 697 / 705 |
pancreas | 61% | 600.82 | 201 / 328 | 99% | 35.80 | 176 / 178 |
adipose | 100% | 4133.94 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 30.58 | 80 / 80 |
spleen | 100% | 4593.63 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 14.78 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 45.26 | 1 / 1 |
blood vessel | 100% | 4509.64 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 9513.91 | 927 / 929 | 0% | 0 | 0 / 0 |
muscle | 100% | 3561.56 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 2196.81 | 841 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 18.80 | 27 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1901532 | Biological process | regulation of hematopoietic progenitor cell differentiation |
GO_0035264 | Biological process | multicellular organism growth |
GO_0030850 | Biological process | prostate gland development |
GO_0060534 | Biological process | trachea cartilage development |
GO_0042789 | Biological process | mRNA transcription by RNA polymerase II |
GO_0032689 | Biological process | negative regulation of type II interferon production |
GO_0006468 | Biological process | protein phosphorylation |
GO_0048384 | Biological process | retinoic acid receptor signaling pathway |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_0071300 | Biological process | cellular response to retinoic acid |
GO_0031641 | Biological process | regulation of myelination |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0001657 | Biological process | ureteric bud development |
GO_0060010 | Biological process | Sertoli cell fate commitment |
GO_1902894 | Biological process | negative regulation of miRNA transcription |
GO_0002068 | Biological process | glandular epithelial cell development |
GO_0007565 | Biological process | female pregnancy |
GO_0051099 | Biological process | positive regulation of binding |
GO_0043277 | Biological process | apoptotic cell clearance |
GO_0032754 | Biological process | positive regulation of interleukin-5 production |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0007281 | Biological process | germ cell development |
GO_0060324 | Biological process | face development |
GO_0001843 | Biological process | neural tube closure |
GO_0031076 | Biological process | embryonic camera-type eye development |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0032526 | Biological process | response to retinoic acid |
GO_0045787 | Biological process | positive regulation of cell cycle |
GO_0045630 | Biological process | positive regulation of T-helper 2 cell differentiation |
GO_0032355 | Biological process | response to estradiol |
GO_0021766 | Biological process | hippocampus development |
GO_0032753 | Biological process | positive regulation of interleukin-4 production |
GO_0032736 | Biological process | positive regulation of interleukin-13 production |
GO_0071391 | Biological process | cellular response to estrogen stimulus |
GO_0001889 | Biological process | liver development |
GO_0045471 | Biological process | response to ethanol |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0017148 | Biological process | negative regulation of translation |
GO_0060591 | Biological process | chondroblast differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0003417 | Biological process | growth plate cartilage development |
GO_0034097 | Biological process | response to cytokine |
GO_0060173 | Biological process | limb development |
GO_0033189 | Biological process | response to vitamin A |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0048167 | Biological process | regulation of synaptic plasticity |
GO_0030154 | Biological process | cell differentiation |
GO_0030853 | Biological process | negative regulation of granulocyte differentiation |
GO_0009755 | Biological process | hormone-mediated signaling pathway |
GO_0045666 | Biological process | positive regulation of neuron differentiation |
GO_0055012 | Biological process | ventricular cardiac muscle cell differentiation |
GO_0061037 | Biological process | negative regulation of cartilage development |
GO_0005634 | Cellular component | nucleus |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030425 | Cellular component | dendrite |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005886 | Cellular component | plasma membrane |
GO_0032991 | Cellular component | protein-containing complex |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0001223 | Molecular function | transcription coactivator binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0031490 | Molecular function | chromatin DNA binding |
GO_0051018 | Molecular function | protein kinase A binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_1901363 | Molecular function | heterocyclic compound binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0044323 | Molecular function | retinoic acid-responsive element binding |
GO_0001217 | Molecular function | DNA-binding transcription repressor activity |
GO_0042826 | Molecular function | histone deacetylase binding |
GO_0019899 | Molecular function | enzyme binding |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_0051393 | Molecular function | alpha-actinin binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0001972 | Molecular function | retinoic acid binding |
GO_0005515 | Molecular function | protein binding |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0048027 | Molecular function | mRNA 5'-UTR binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000900 | Molecular function | mRNA regulatory element binding translation repressor activity |
GO_0043422 | Molecular function | protein kinase B binding |
Gene name | RARA |
Protein name | RARA protein Retinoic acid receptor alpha Retinoic acid nuclear receptor alpha variant 2 (Retinoic acid receptor, alpha, isoform CRA_b) Retinoic acid receptor alpha (RAR-alpha) (Nuclear receptor subfamily 1 group B member 1) Retinoic acid receptor alpha (Retinoic acid receptor, alpha, isoform CRA_e) RARA protein (Retinoic acid nuclear receptor alpha variant 1) (Retinoic acid receptor, alpha, isoform CRA_c) (cDNA, FLJ92939, Homo sapiens retinoic acid receptor, alpha (RARA), mRNA) |
Synonyms | NR1B1 hCG_2007196 |
Description | FUNCTION: Receptor for retinoic acid . Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes . The RXR/RAR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5 . In the absence of ligand, the RXR-RAR heterodimers associate with a multiprotein complex containing transcription corepressors that induce histone deacetylation, chromatin condensation and transcriptional suppression . On ligand binding, the corepressors dissociate from the receptors and associate with the coactivators leading to transcriptional activation . Formation of a complex with histone deacetylases might lead to inhibition of RARE DNA element binding and to transcriptional repression . Transcriptional activation and RARE DNA element binding might be supported by the transcription factor KLF2 . RARA plays an essential role in the regulation of retinoic acid-induced germ cell development during spermatogenesis (By similarity). Has a role in the survival of early spermatocytes at the beginning prophase of meiosis (By similarity). In Sertoli cells, may promote the survival and development of early meiotic prophase spermatocytes (By similarity). In concert with RARG, required for skeletal growth, matrix homeostasis and growth plate function (By similarity). Together with RXRA, positively regulates microRNA-10a expression, thereby inhibiting the GATA6/VCAM1 signaling response to pulsatile shear stress in vascular endothelial cells . In association with HDAC3, HDAC5 and HDAC7 corepressors, plays a role in the repression of microRNA-10a and thereby promotes the inflammatory response . . |
Accessions | J3KSJ4 J3QRM2 A8MUP8 ENST00000394089.6 [P10276-1] Q15997 ENST00000394081.7 [P10276-2] ENST00000475125.1 ENST00000577646.5 ENST00000254066.10 [P10276-1] ENST00000425707.7 [P10276-3] Q6I9R7 F1D8N9 P10276 ENST00000394086.7 |